Related Experiment Video
Updated: Feb 23, 2026
Analysis of Cell Cycle Position in Mammalian Cells
Published on: January 21, 2012
Inhibition of E2F1 activity and cell cycle progression by arsenic via retinoblastoma protein
1a Geisel School of Medicine at Dartmouth, Department of Molecular and Systems Biology , Hanover , NH , USA.
Abstract:
The regulation of cell cycle progression by steroid hormones and growth factors is important for maintaining normal cellular processes including development and cell proliferation. Deregulated progression through the G1/S and G2/M cell cycle transitions can lead to uncontrolled cell proliferation and cancer. The transcription factor E2F1, a key cell cycle regulator, targets genes encoding proteins that regulate cell cycle progression through the G1/S transition as well as proteins important in DNA repair and apoptosis. E2F1 expression and activity is inhibited by inorganic arsenic (iAs) that has a dual role as a cancer therapeutic and as a toxin that leads to diseases including cancer. An understanding of what underlies this dichotomy will contribute to understanding how to use iAs as a more effective therapeutic and also how to treat cancers that iAs promotes. Here, we show that quiescent breast adenocarcinoma MCF-7 cells treated with 17-β estradiol (E2) progress through the cell cycle, but few cells treated with E2 + iAs progress from G1 into S-phase due to a block in cell cycle progression. Our data support a model in which iAs inhibits the dissociation of E2F1 from the tumor suppressor, retinoblastoma protein (pRB) due to changes in pRB phosphorylation which leads to decreased E2F1 transcriptional activity. These findings present an explanation for how iAs can disrupt cell cycle progression through E2F1-pRB and has implications for how iAs acts as a cancer therapeutic as well as how it may promote tumorigenesis through decreased DNA repair.
Insights
Inorganic arsenic (iAs) blocks cell cycle progression by inhibiting E2F1-pRB complex dissociation, impacting cancer therapy and promotion. Understanding this mechanism is key for iAs therapeutic use and cancer treatment.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- Cell cycle regulation is crucial for normal cellular processes, with disruptions leading to cancer.
- The transcription factor E2F1 regulates cell cycle progression, DNA repair, and apoptosis.
- Inorganic arsenic (iAs) exhibits a dual role, acting as both a cancer therapeutic and a carcinogen.
Purpose of the Study:
- To investigate the mechanism by which inorganic arsenic (iAs) inhibits cell cycle progression.
- To elucidate the role of the E2F1-retinoblastoma protein (pRB) complex in iAs-induced cell cycle arrest.
- To understand the implications of iAs's effect on cell cycle regulation for cancer therapy and tumorigenesis.
Main Methods:
- Utilized breast adenocarcinoma MCF-7 cells.
- Treated cells with 17-β estradiol (E2) alone and in combination with iAs.
- Analyzed cell cycle progression from G1 to S-phase.
- Investigated the interaction and phosphorylation status of E2F1 and pRB.
Main Results:
- E2 treatment promoted cell cycle progression in quiescent MCF-7 cells.
- Co-treatment with E2 and iAs resulted in a block in cell cycle progression at the G1/S transition.
- iAs inhibited the dissociation of E2F1 from pRB, attributed to altered pRB phosphorylation.
- This inhibition led to decreased E2F1 transcriptional activity.
Conclusions:
- iAs disrupts cell cycle progression by interfering with the E2F1-pRB complex.
- Altered pRB phosphorylation is a key mechanism underlying iAs's effect on E2F1.
- Findings provide insights into iAs's dual role in cancer therapy and promotion, particularly concerning DNA repair.
- Understanding this mechanism can inform the development of more effective iAs-based cancer therapies and strategies to mitigate iAs-induced tumorigenesis.
Related Concept Videos
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
02:34Inhibition of Cdk Activity
01:23Negative Regulator Molecules
02:38Mitogens and the Cell Cycle
02:23Abnormal Proliferation
02:36DNA Damage can Stall the Cell Cycle